Comparation of CART19 and autologous stem-cell transplantation for refractory/relapsed non-Hodgkin's lymphoma.
Li C, Zhang Y, Zhang C, Chen J, Lou X, Chen X, Kang L, Xu N, Li M, Tan J, Sun X, Zhou J, Yang Z, Zong X, Wang P, Xu T, Qu C, Huang H, Jin Z, Yu L, Wu D.
Li C, et al. Among authors: jin z.
JCI Insight. 2019 Jul 23;5(17):e130195. doi: 10.1172/jci.insight.130195.
JCI Insight. 2019.
PMID: 31335321
Free PMC article.